Ada Wiśniowska

Ada Wiśniowska

Auto-generated profile, based on publicly available information

Ada Wiśniowska

Warsaw Medical University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AWAda Wiśniowska
Ada Wiśniowska
MWMaksymilian Wiśniowski
Maksymilian Wiśniowski
AKAleksandra Kozłowska
Aleksandra Kozłowska
Introduction: This review aims to assess the current evidence on the efficacy and safety of low-dose radiotherapy (LDRT) in the treatment of non-malignant musculoskeletal and orthopaedic disorders, including osteoarthritis, plantar fasciitis, calcaneal spur, enthesopathies, Dupuytren’s contracture, Ledderhose disease, and heterotopic ossification. As the prevalence of such conditions rises due to aging populations and modern lifestyle factors, interest is growing in alternative therapies for patients unresponsive to standard conservative treatment. State of the Art: LDRT has been used in Germany for decades and is now gaining wider clinical attention. Its mechanisms—primarily anti-inflammatory and immunomodulatory—include suppression of pro-inflammatory cytokines and modulation of macrophage phenotypes. Recent studies show pain reduction in 42–95% of patients, with complete remission in up to 81%, depending on the condition, dosage, and treatment schedule. Comparable efficacy is seen between lower (0.5 Gy/fraction) and higher (1.0 Gy/fraction) dosing regimens. LDRT has shown particular benefit in early-stage fibromatoses and in postoperative prevention of heterotopic ossification, where combination with NSAIDs enhances efficacy. Safety data indicate minimal adverse effects and no significant increase in malignancy risk. However, some randomized trials report outcomes similar to placebo, highlighting the need for further controlled research. Conclusions: LDRT is a safe and promising adjunctive therapy in selected orthopaedic conditions, especially where conventional treatments have failed or are contraindicated. While long-term safety appears acceptable, further sham-controlled trials, biomarker studies, and treatment standardization are essential. This review is primarily intended for clinicians seeking evidence-based alternatives for managing chronic musculoskeletal disorders.

11 May 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KKKlaudia Kulig
Klaudia Kulig
MWMaksymilian Wiśniowski
Maksymilian Wiśniowski
ARAneta Redner
Aneta Redner
MPMichal Popiel
Michal Popiel
KDKamil Dziekoński
Kamil Dziekoński
AWAda Wiśniowska
Ada Wiśniowska
Introduction: Radiotherapy, once limited to oncology, is now emerging as a therapeutic option for non-neoplastic neurological disorders. Advances in stereotactic techniques such as Gamma Knife and CyberKnife allow for precise functional targeting, opening possibilities in diseases like Alzheimer’s disease (AD), drug-resistant epilepsy, and trigeminal neuralgia (TN).Materials and Methods: A comprehensive literature review was conducted using PubMed, Scopus, and ClinicalTrials.gov. Search terms included radiotherapy, stereotactic radiosurgery, Alzheimer’s disease, epilepsy, and trigeminal neuralgia. Studies published between 2015–2025 were reviewed.Results: In AD, low-dose radiation therapy (LDRT) has shown potential to stabilize or improve cognition, with minimal side effects in early clinical trials. In epilepsy, stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) have provided seizure reduction or remission in selected cases, particularly where surgery is not viable. For TN, SRS achieves pain relief in 85–90% of patients, with long-term remission and generally mild adverse effects such as facial numbness.Conclusions: Radiotherapy offers a promising, non-invasive approach for selected neurological conditions. Although current data are encouraging, larger randomized trials are essential to establish long-term safety, optimize dosing strategies, and validate efficacy across patient populations.

5 December 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
MWMaksymilian Wiśniowski
Maksymilian Wiśniowski
AWAda Wiśniowska
Ada Wiśniowska
KBKacper Buczek
Kacper Buczek
KKKatarzyna Kulszo
Katarzyna Kulszo
BBBartłomiej Baszun
Bartłomiej Baszun
AKAleksandra Kozłowska
Aleksandra Kozłowska
Introduction: Radiotherapy (RT) is a cornerstone in cancer treatment, but its success is often hindered by tumor radioresistance and normal tissue toxicity. Vitamins A and C are being investigated as potential adjuvants to modulate RT outcomes through radiosensitizing, radioprotective, and immune-regulatory mechanisms.Methods and Materials: We reviewed preclinical and clinical studies from PubMed, ScienceDirect, ResearchGate, and Google Scholar using keywords like “radiotherapy”, ”radiation”, “vitamin A”, “vitamin C”, “retinol”, “β-carotene”, “α-carotene”, “β-cryptoxanthin”, “ascorbic acid” and “radiosensitivity”.Results: Vitamin A, particularly all-trans retinoic acid (ATRA), enhances radiosensitivity by promoting immune-mediated tumor regression, impairing DNA repair in cancer stem cells, and reducing radiation-induced normal tissue damage. However, clinical data on β-carotene suggest potential risks, including increased recurrence in some populations (e.g., smokers). Vitamin C shows dose-dependent effects: at physiological levels, it protects normal tissues via antioxidant activity, while at pharmacological intravenous doses, it selectively sensitizes tumors through pro-oxidant mechanisms. Clinical trials indicate potential for mitigating RT toxicity, such as improved xerostomia, but evidence is currently limited.Conclusions: Vitamins A and C may enhance the therapeutic ratio of radiotherapy via distinct biological mechanisms. However, their clinical use requires careful consideration of dose, timing, and patient-specific factors. Further research through well-designed trials is needed to establish optimal protocols and identify which patients are most likely to benefit.

16 June 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MWMaksymilian Wiśniowski
Maksymilian Wiśniowski
KKKlaudia Kulig
Klaudia Kulig
AWAda Wiśniowska
Ada Wiśniowska
KBKacper Buczek
Kacper Buczek
PZPatrycja Zwierzchlewska
Patrycja Zwierzchlewska
JDJulia Dąbrowska
Julia Dąbrowska
Introduction and aim: Radiotherapy is a fundamental component of cancer treatment but is limited by tumor radioresistance and damage to healthy tissues. Polyphenols—plant-derived compounds with antioxidant, anti-inflammatory, and anticancer properties—have gained attention for their potential to modulate radiotherapy outcomes. This review aims to evaluate preclinical and clinical evidence on the effects of selected polyphenols in combination with radiotherapy.Materials and methods: A comprehensive literature search was conducted using PubMed, ScienceDirect, ResearchGate, and Google Scholar, focusing on studies from the last two decades. Search terms included: radiotherapy, radiation. polyphenols, curcumin, genistein, chrysin, ellagic acid, resveratrol, quercetin, apigenin, epicatechin, kaempferol, caffeic acid, gallic acid. Both in vitro and in vivo studies were included, as well as available clinical trials.Results: Several polyphenols—including curcumin, genistein, ellagic acid, resveratrol, and quercetin—demonstrated the ability to enhance radiosensitivity in tumor cells or protect normal tissues. Curcumin and genistein have shown early clinical benefits, particularly in head and neck and prostate cancer patients. However, most polyphenols remain in the preclinical stage.Conclusion: Polyphenols show promise as adjuncts to radiotherapy, with context-dependent radiosensitizing or radioprotective effects. Further clinical trials are necessary to validate efficacy, safety, and optimal dosing before integration into standard oncology protocols.

17 February 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
AWAda Wiśniowska
Ada Wiśniowska
MWMaksymilian Wiśniowski
Maksymilian Wiśniowski
KBKacper Buczek
Kacper Buczek
AKAleksandra Kozłowska
Aleksandra Kozłowska
Introduction: Radiotherapy (RT) is the fundamental method in cancer treatment, yet tumor resistance and normal tissue toxicity limit its efficacy. Vitamins D and E may modulate RT outcomes through radiosensitization, antioxidant effects, and immune regulation.Methods and Materials: We reviewed preclinical and clinical studies from PubMed, ScienceDirect, ResearchGate, and Google Scholar using keywords like “radiotherapy”, ”radiation”, “vitamin D”, “vitamin E” and “radiosensitivity”.Results: Vitamin D enhances RT response via VDR-mediated DNA damage and reduces toxicity (e.g., mucositis), though hypercalcemia risk requires monitoring. Vitamin E (especially tocotrienols) alleviates mucositis and fibrosis, but excessive doses may compromise RT efficacy by neutralizing tumor-killing ROS.Conclusions: Vitamins D and E show therapeutic potential in RT but require precise dosing and timing to avoid interference with treatment. Personalized strategies and robust clinical trials are needed to establish evidence-based guidelines for their adjuvant use.

16 May 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MWMaksymilian Wiśniowski
Maksymilian Wiśniowski
KKKlaudia Kulig
Klaudia Kulig
KBKacper Buczek
Kacper Buczek
MPMichal Popiel
Michal Popiel
KDKamil Dziekoński
Kamil Dziekoński
KSKamila Smala
Kamila Smala
Purpose of research: Paragliding is a popular extreme sport offering physical and mental benefits but posing significant injury risks. This study analyzes its health impact, focusing on benefits, risks, and epidemiological trends.Research materials and methods: A systematic review was conducted using PubMed, ResearchGate, and Google Scholar. Keywords included: “paragliding”, “health”, “epidemiology”, "injuries". Studies on injury patterns, fatalities, and health effects were analyzed.Basic results: Paragliding enhances cardiovascular fitness, cognitive function, and stress resilience. However, the sport carries a high risk of injuries, primarily affecting the lower extremities and spine. Epidemiological studies show regional variations in accident rates, with fatalities often linked to pilot error and weather conditions.Conclusions: While paragliding offers health benefits, its risks necessitate strict safety measures, training, and protective gear. Future research should focus on injury prevention, long-term health effects, and improved safety strategies to balance the sport’s benefits with risk management.